What is Infliximab?

Category: Prescription Drugs

Most popular types: Remicade Revellex Infimab Show all

false

Infliximab is a monoclonal antibody used in the treatment of a number of autoimmune conditions, including: Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Crohn's disease 1937 76
Rheumatoid arthritis 1657 57
Psoriatic arthritis 213 24
Ulcerative colitis 210 24
Ankylosing spondylitis 152 16
Psoriasis 133 8

Show all 49 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 29
Moderate 41
Mild 57
None 73

Commonly reported side effects and conditions associated with Infliximab

Side effect Patients Percentage
Fatigue 20
Nausea 11
Headaches 10
Joint pain 7
Muscle and joint pain 6
Anaphylaxis 4

Show all 84 reported side effects

Dosages

Based on patients currently taking Infliximab

Dosage Patients Percentage
10 mL monthly 1
100 mg every 8 weeks 1
100 mg every 6 weeks 1
100 mg monthly 1
500 mL every 6 weeks 1
750 mg every 6 weeks 1

Why patients stopped taking Infliximab

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 82
Side effects too severe 61
Other 45
Doctor's advice 42
Expense 18
Change in health plan coverage 10
Course of treatment ended 6
Personal research 1
See all 193 patients who've stopped taking Infliximab

Duration

Currently taking Infliximab

Duration Patients Percentage
6 months - 1 year 2
1 - 2 years 1
2 - 5 years 2
5 - 10 years 1
10 years or more 1

Stopped taking Infliximab

Duration Patients Percentage
Less than 1 month 33
1 - 6 months 29
6 months - 1 year 36
1 - 2 years 32
2 - 5 years 39
5 - 10 years 14
10 years or more 5
Adherence
Adherence Evaluations Percentage
Always 175
Usually 10
Sometimes 6
Never taken as prescribed 9
Burden
Burden Evaluations Percentage
Very hard to take 13
Somewhat hard to take 73
A little hard to take 57
Not at all hard to take 57
Cost per month
Cost per month Evaluations Percentage
$200+ 30
$100-199 10
$50-99 7
$25-49 5
< $25 48
Not specified 100

What people switch to and from

Patients started taking Infliximab after stopping:

Treatment Patients Percentage
Adalimumab (Humira) 24
Etanercept (Enbrel) 10
Mesalamine (Pentasa) 10
Prednisone (Prednisone Intensol) 8
Methotrexate (Apo-Methotrexate) 7

Show all 33 treatments patients report switching from

Patients stopped taking Infliximab and switched to:

Treatment Patients Percentage
Adalimumab (Humira) 46
Abatacept (Orencia) 12
Golimumab (Simponi) 9
Certolizumab (Cimzia) 6
Tocilizumab (Actemra) 6

Show all 23 treatments patients report switching to

Last updated:

9 patient evaluations for Infliximab

Mar 22, 2017 (Started Mar 03, 2017)

  • Effectiveness
    Slight (for psoriasis worsened)
  • Effectiveness
    Slight (for psoriatic arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 6 mg Every 8 Weeks

  • 0 helpful marks

Jul 21, 2016 (Started Dec 12, 2015)

  • Effectiveness
    Moderate (for Crohn's disease)
  • Effectiveness
    Major (for rheumatoid arthritis)
  • Side effects
    Moderate (dry throat, dry skin, rash or skin problems)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg Every 8 Weeks
Advice & Tips: It takes commitment and time to work. My infusions are done at the GI clinic while some are outpatient at hospital. They take 3-4 hours and usually am extremely tired and groggy for couple of days.
Cost: $200+ monthly

  • 1 helpful mark

Jun 25, 2013 (Started Jul 01, 2005)

  • Effectiveness
    Major (for Crohn's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 750 mg Every 6 Weeks

  • 0 helpful marks
Last updated:
Showing 3 of 9 patient evaluations for Infliximab